Spago Nanomedical Publishes the Annual Report for 2023

LUND, SE / ACCESSWIRE / May 16, 2024 / Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F)

Spago Nanomedical's annual report for 2023 is from today available at the company's website, https://spagonanomedical.se/investor-relations/#financial-reports

For further information, please contact Mats Hansen, CEO Spago Nanomedical AB, [phone], [e-mail]

Spago Nanomedical AB is a Swedish company in clinical development phase. The company´s development projects are based on a platform of polymeric materials with unique properties for more precise treatment and diagnosis of cancer and other debilitating diseases. Spago Nanomedical´s share is listed on Nasdaq First North Growth Market (ticker: SPAGO). For further information, see www.spagonanomedical.se.

FNCA Sweden AB is the Certified Adviser of the company.

Attachments

Spago Nanomedical - Annual Report 2023

SOURCE: Spago Nanomedical

View the original press release on accesswire.com


The Spago Nanomedical Stock at the time of publication of the news with a raise of 0,00 % to 0,020EUR on Frankfurt stock exchange (16. Mai 2024, 08:59 Uhr).